Related Experiment Video
Updated: Apr 28, 2026
11:34
A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
2.2K
Possible factors affecting thyroid dysfunction in hepatitis C virus-infected untreated patients
Xiao-Rong Mao1, Li-Ting Zhang2, Hong Chen2
1Department of Infectious Diseases, The First Hospital of Lanzhou University, Lanzhou, Gansu 730000, P.R. China ; Department of General Surgery, The Second Hospital of Lanzhou University, Lanzhou, Gansu 730030, P.R. China.
Experimental and Therapeutic Medicine
|June 20, 2014
Summary
Thyroid dysfunction (TD) is linked to chronic hepatitis C virus (HCV) infection, particularly in middle-aged females. Autoimmunity may play a role, and TD patients show higher liver dysfunction rates, suggesting personalized treatment approaches for HCV patients.
Area of Science:
- Hepatology and Endocrinology
- Virology and Immunology
Background:
- Chronic hepatitis C virus (HCV) infection affects liver health globally.
- Thyroid dysfunction (TD) is a common endocrine disorder with various potential systemic implications.
- The interplay between HCV infection and TD requires further investigation to understand disease pathogenesis and patient outcomes.
Purpose of the Study:
- To investigate the association between thyroid dysfunction (TD) and chronic hepatitis C virus (HCV) infection in untreated patients.
- To explore geographical variations and demographic factors influencing TD in HCV-infected individuals.
- To examine the relationship between HCV RNA levels, autoimmunity, and liver function in patients with and without TD.
Main Methods:
- Retrospective analysis of 1,012 untreated HCV-infected patients.
- Categorization of patients based on the presence and type of thyroid dysfunction.
- Assessment of HCV RNA expression levels, HCV genotypes, and liver function tests.
Main Results:
- 209 out of 1,012 patients had TD, with geographical variations observed.
- Female patients exhibited a higher incidence of autoimmune-related TD.
- HCV RNA levels were not correlated with TD pathogenesis but suggested an association with autoimmunity; TD patients had higher liver dysfunction rates.
Conclusions:
- Thyroid dysfunction is associated with chronic hepatitis C virus infection, particularly in middle-aged females.
- Autoimmunity appears to be a significant factor in the pathogenesis of TD in HCV patients.
- The presence of TD in HCV-infected individuals is linked to increased liver dysfunction, supporting the need for individualized treatment strategies.
Related Concept Videos
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
271
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
271
01:25Hepatitis
80
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
80
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
380
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
380
01:23Hypothyroidism II: Pathophysiology
20
Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
20
01:28Graves' Disease I: Introduction
19
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence...
19
01:27Hyperthyroidism II: Pathophysiology
26
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH...
26